Design and rationale of FOCUS (PX-171-011): A randomized, open-label, phase 3 study of carfilzomib versus best supportive care regimen in patients with relapsed and refractory multiple myeloma (R/R MM…

Overview of attention for article published in BMC Cancer, September 2012

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 42 Dimensions

Readers on

mendeley: 64 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

IMMUNOGLOBULIN EXPRESSION LEVELS AS BIOMARKER FOR PROTEASOME INHIBITOR RESPONSE

Application WO-2015021376-A1

World Intellectual Property Organisation (WIPO)